World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Group
Pharmaceutical Generics.
10/22/2006
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06.15.2013
More Low-Cost Generics - WSJ.com
Wall Street Journal 10.22.2006
For Booming Biotech Firms, A New Threat: Generics
Wall Street Journal 03.14.2007
In Trade Deal, a Shift on Generics
Wall Street Journal 05.17.2007
Wall Street Journal 02.06.2008
Daiichi Targets Generics to Extend Reach
Wall Street Journal 06.12.2008
Generics Hurt Sanofi's Sales But Firm Lifts Profit Outlook
Wall Street Journal 11.01.2008
FTC Clears Teva Acquisition of Bar
Wall Street Journal 12.20.2008
Ending the Silence of Generic Drugmakers
BusinessWeek 06.24.2010
Deals to Keep Generic Drugs Off Market Get a Court Rebuff
New York Times 07.26.2012
Top Court in India Rejects Novartis Drug Patent
New York Times 04.01.2013
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us